摘要
目的:研究阿尔茨海默病(AD),遗忘型轻度认知功能障碍(aMCI患者)和正常老化的海马差异。材料与方法:本研究经当地伦理审查委员会和知情同意书的志愿者/监护人获得。这项研究包括60例:20 aMCI患者患者,20 AD患者和20例正常对照组(NC组)。进行磁共振成像和海马弥散峰度成像测试。非线性拟合程序和方程被用来计算平均扩散(MD)和平均峰度(MK)。Fisher至小显著差异检验(双样本t检验比较)用于三组海马的双边MK/ MD值/体积方差分析。通过Pearson相关系数对简易精神状态检查(MMSE)成绩和MK/ MD值/卷之间的相关性进行计算。结果:共有的AD与NC组之间以及AD和aMCI患者组归一化侧海马体积之间有显著的差异。有左边和右边海马MK值在NC、aMCI患者和AD组间存在差异显著。对于右海马的MD值, NC和AD组之间也存在显著差异。对于左海马MD值,AD与NC组之间以及AD和aMCI患者群体之间也存在差异显著。对于MMSE评分和海马MK/ MD值/体积之间的所有Pearson相关系数都存在显著差异。结论:双侧海马MK/ MD值比aMCI患者和AD患者诊断时的体积指标更加敏感。
关键词: 阿尔茨海默病,健忘轻度认知损伤,弥散峰度成像,海马,磁共振成像。
Current Alzheimer Research
Title:Examination of Hippocampal Differences Between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion Kurtosis
Volume: 12 Issue: 1
Author(s): Dan Wang, Zhao-Hui Guo, Xing-Han Liu, Yue-Hua Li and He Wang
Affiliation:
关键词: 阿尔茨海默病,健忘轻度认知损伤,弥散峰度成像,海马,磁共振成像。
摘要: Purpose: To examine hippocampal differences between Alzheimer disease (AD), amnestic mild cognitive impairment (aMCI) and normal aging. Materials and methods: This study was approved by the local ethics review board, and informed consent was obtained from volunteers/guardians. The study comprised 60 subjects: 20 aMCI patients, 20 AD patients and 20 normal controls (NC group). Magnetic resonance imaging and diffusion kurtosis imaging of the hippocampus were performed. Nonlinear fitting routines and equations were used to calculate mean diffusion (MD) and mean kurtosis (MK). Analysis of variance was used to compare the bilateral MK/MD values/volumes of the hippocampus for the three groups using the Fisher least significant difference test (a two-sample t-test comparison). Pearson correlation coefficients were calculated for the correlations between mini-mental state examination (MMSE) scores and MK/MD values/volumes. Results: There were significant differences between the AD and NC groups and between the AD and aMCI groups in terms of normalized bilateral hippocampal volume. There were significant differences between the NC, aMCI and AD groups in terms of both right and left hippocampus MK values. For the right hippocampus MD values, there was a significant difference between the NC and AD groups. For the left hippocampus MD values, there were significant differences between the AD and NC groups and between the AD and aMCI groups. Pearson correlation coefficients for all correlations between MMSE scores and hippocampus MK/MD values/volumes were significant. Conclusion: The bilateral hippocampal MK/MD values may be more sensitive than volumes in the diagnosis of aMCI and AD patients.
Export Options
About this article
Cite this article as:
Dan Wang, Zhao-Hui Guo, Xing-Han Liu, Yue-Hua Li and He Wang , Examination of Hippocampal Differences Between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion Kurtosis, Current Alzheimer Research 2015; 12 (1) . https://dx.doi.org/10.2174/1567205012666141218142422
DOI https://dx.doi.org/10.2174/1567205012666141218142422 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Na+ Channel Pharmacology and Molecular Mechanisms of Gating
Current Pharmaceutical Design Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
Current Pharmaceutical Design CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease
Current Drug Metabolism SPECT Radiopharmaceuticals for Dementia
Current Radiopharmaceuticals Implications of Prion Protein Biology
Current Neurovascular Research Synaptic Plasticity, Metaplasticity and Depression
Current Neuropharmacology Editorial [Hot Topic: New Mechanisms of Neuronal Injury and Neuroprotection (Guest Editor: Weihai Ying)]
Current Drug Targets Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
Current Genomics Aquaporins and Roles in Brain Health and Brain Injury
Mini-Reviews in Medicinal Chemistry Clinical and Electroencephalographic Assessment of Cefepime During Treatment of Nosocomial Infections in Neurological Patients
Central Nervous System Agents in Medicinal Chemistry ABAD: A Potential Therapeutic Target for Aβ-Induced Mitochondrial Dysfunction in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Discovery of New Inhibitors of Urease Enzyme: A Study Using STD-NMR Spectroscopy
Letters in Drug Design & Discovery Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
Current Neuropharmacology From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
Current Neuropharmacology Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery